跳至主要内容
临床试验/NCT02580929
NCT02580929Unknown不适用

Effectiveness of Radiotherapy Before Surgery in Patients With High-risk Relapse Hepatocellular Carcinoma

Peking Union Medical College1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2014年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
50
试验地点
1
主要终点
mortality

研究概览

简要总结

This study aims to evaluate the effectiveness of radiotherapy before surgery in high-risk relapse hepatocellular cancer patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of HCC
  • In high risk of recurrence of HCC but still can endure palliative resection
  • KPS scores are >90
  • With Child-Pugh Class A liver funcion, serum bilirubin< 1.5*normal maxism; ALT and AST< 1.5*normal maxism; normal creatinine and urea nitrogen; WBC>4×109/L, Hb>110g/L, PLT>90X109/L.
  • Have signed informed consent

排除标准

  • HCC cannot be operated
  • With Child-Pugh Class B/C
  • Have other organ cancer, excluding curative non-melanotic skin cancer and carcinoma in situ of cervix
  • Have other severe disease
  • With active hepatitis
  • Have accepted local radiation therapy in other hospitals
  • KPS scores≤70
  • Tumor edges cannot be defined
  • Have severe cirrhosis complication
  • Intensity modulated radiation therapy cannot reach required dose
  • Cannot cooperate
  • Lactant or pregnant
  • Cannnot be informed

结局指标

主要结局

mortality

时间窗: 5 years

次要结局

未报告次要终点

研究者

发起方
Peking Union Medical College
申办方类型
Other
责任方
Principal Investigator
主要研究者

WU FAN

Doctor

Peking Union Medical College

研究点 (1)

Loading locations...

相似试验